Skip to content
PreclinicalResearch compoundModerate evidence

Pramiracetam

Experimental nootropic, a stronger relative of piracetam; studied mainly in animals and not proven in humans.

NootropicRacetamMemoryFocusCholinergicAcetylcholineAMPA

Pharmacology

ClassRacetam · Memory · Focus · Cholinergic
Primary targetHigh-affinity choline transporter CHT1 (HACU)
Targets3 receptor targets
EvidenceModerate evidence
Affected systemsAcetylcholineAMPA

Contents

Related comparisons

Pramiracetam vs Coluracetam

DETAILED OVERVIEW

What is Pramiracetam?

Pramiracetam is a stronger relative of piracetam, an experimental brain-supporting compound. In Italy it was used as a prescription medicine under the name Pramistar, but it has been withdrawn in several markets; in the United States it is not an approved medicine.

In a part of the brain important for memory, it helps cells take up choline (a building block of acetylcholine), so more acetylcholine, a brain messenger involved in memory and learning, may be made. So far it has been studied mainly in animals, and its effect in humans is not proven. Irritability is the most commonly reported complaint; headache and brain fog also occur, mostly when choline intake is too low. Tolerance may develop with long-term use. It is best avoided in pregnancy and breastfeeding, as there is no safety data. Lasting stress (high corticosteroid levels) may block its memory-improving effect.

Mechanism

Boosts choline uptake; strengthens the AMPA receptor

Half-life

4-6 h

Legal status

EU Rx (IT, withdrawn)

Receptor profile

  • Choline transporter CHT1 (HACU)Strong
  • Cerebral blood flowModerate
  • AMPA glutamate receptorWeak

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Headache, often due to choline depletion (well mitigated by a choline source such as alpha-GPC or CDP-choline)
  • Irritability and tension (the most frequently reported side effect)
  • Brain fog and mental dullness, typically with inadequate choline
  • Tiredness and fatigue
  • Tolerance development with prolonged, uninterrupted use
  • Nervousness or mild restlessness, especially at higher doses

Contraindications · 5

  • Pregnancy and breastfeeding: no safety data, should be avoided
  • Severe renal or hepatic impairment: caution, as clearance may be affected
  • Concurrent cholinergic drugs (e.g. cholinesterase inhibitors): cholinergic effects may be additive
  • Inadequate choline intake: increases risk of headache and brain fog, a choline source is advised
  • Chronic stress with elevated corticosteroids: may block the memory-enhancing effect

Related Nootropics

Same therapeutic category

FAQ

FAQ

Pramiracetam is a stronger, cholinergic-type relative of piracetam, developed mainly to boost the brain's acetylcholine turnover, the messenger chemical that plays a key role in memory and learning. According to the description, it helps facilitate choline uptake in the brain and may also influence glutamatergic (AMPA) signaling, which in theory could support better focus and memory performance. The source doesn't list specific, concrete benefits, so nothing more definite can be said based on the available data.

Telegram

Have a question about Pramiracetam?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC14H27N3O2
UpdatedOctober 14, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.